SB 1136 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority (OHCA) for unspecified duties required by law. The bill directly affects the OHCA, which administers state health care programs, by providing dedicated funding for its operations. It requires the agency to use these specific funds for purposes outlined in existing law, though the bill does not detail the exact programs or services. The funding is effective immediately upon the bill's passage, declared an emergency for public health and safety reasons. This is a routine appropriations measure with no new policy requirements or beneficiary changes.
SB 176 requires health insurance plans to cover certain prescription drugs that were previously not included in standard coverage. It directly affects health insurance providers and policyholders by mandating this specific coverage for eligible medications. The key provision is a new requirement for all health benefit plans to include these designated prescriptions without prior authorization or excessive cost-sharing. The law became effective on May 29, 2025, after the Governor did not sign it.
SB 1141 allocates $100,000 from unallocated state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for its existing statutory duties. The bill requires these specific funds to be used for mental health services without creating new programs or altering current service requirements. An emergency clause makes the law effective immediately upon passage, bypassing the typical governor's signature requirement. The bill became law on May 29, 2025, after being passed without gubernatorial action.
SB 1140 allocates $100,000 from unspent state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for purposes already required by law. The bill directs the department to use these funds for its existing duties, without creating new programs or services. It includes an emergency provision allowing immediate implementation upon enactment, bypassing the usual waiting period. The bill became law on May 29, 2025, without the governor's signature. This is a procedural funding measure, not a substantive policy change.
HB 2013, "Dylan's Law," requires health insurance companies to cover epilepsy treatments equally to other conditions, prohibits dropping coverage solely due to an epilepsy diagnosis, and mandates coverage for medically necessary neurostimulation devices. It also allows individuals with epilepsy (diagnosed by a licensed doctor) to voluntarily add a unique symbol to their Oklahoma driver's license or ID card by June 1, 2026, to help first responders identify their condition during emergencies. The symbol cannot be used for any other purpose and may be removed at any time. These provisions became law on May 25, 2025, without a gubernatorial signature. The bill directly affects people with epilepsy and insurers operating under the Affordable Care Act in Oklahoma.
HB 2052 exempts certain domestic health maintenance organizations (HMOs) that exclusively contract with Oklahoma's Medicaid program (via the Oklahoma Health Care Authority) from most state health insurance regulations. These HMOs, which serve only Medicaid recipients and no other patients, are no longer subject to specific provisions of the Health Maintenance Organizations Act, including requirements about benefit coverage and certain administrative rules. The exemption applies solely to services provided to Medicaid recipients under Oklahoma Statutes Title 56, Section 4002.2. The law became effective November 1, 2025, after passing without the Governor's signature.
SB 927 amends Oklahoma's Medicaid Drug Utilization Review Board procedures by prohibiting the pharmaceutical industry representative from voting on drug-related matters. It updates the appointment process to stagger initial terms for one physician, one pharmacist, and the lay representative to ensure board continuity. The bill affects the Oklahoma Health Care Authority and the board members, with changes taking effect November 1, 2025. The board's composition (10 members: 4 physicians, 4 pharmacists, 1 lay representative, 1 pharmaceutical industry rep) and appointment lists remain unchanged.
This bill amends Oklahoma law to add a new member representing federally recognized American Indian tribes to the state Medicaid Advisory Committee, expanding the committee's composition to include sixteen members instead of fifteen. The change ensures tribal representation on the advisory body that reviews Medicaid policy, program administration, and health care service delivery for public assistance recipients. The bill also updates appointment terms to a maximum of four consecutive years and clarifies that committee members receive travel reimbursement but no compensation for their service. Effective November 1, 2025, the committee will continue its existing duties of providing recommendations to the Oklahoma Health Care Authority while incorporating the new tribal member's perspective.
SB 947 updates Oklahoma's nursing facility fee structure and fund allocation rules to improve long-term care services for seniors. It revises how the Nursing Facilities Quality of Care Fee is calculated (based on 6% of total patient gross receipts divided by patient days) and designates specific uses for the resulting fund, including funding 15 ombudsmen positions and increasing monthly personal needs allowances for nursing home residents from $30 to $50. The bill ensures these programs - such as Medicaid services, nursing facility inspections, and senior support services - remain exempt from budget cuts. It directly affects nursing facilities (which pay the fee), seniors receiving Medicaid long-term care, and state agencies managing these programs. The bill was enacted without the Governor's signature on May 13, 2025.
HB 2049 requires Oklahoma's Medicaid managed care plans to comply with federal parity laws for mental health and substance use disorder coverage. It mandates regular compliance checks on nonquantitative treatment limitations (like prior authorization), creates a standardized process for handling parity complaints, and requires the Oklahoma Health Care Authority to publicly report on compliance. The law directly affects Medicaid managed care plans, the Oklahoma Health Care Authority, and Medicaid beneficiaries seeking mental health or substance use services. Key provisions include contract requirements for parity analysis, public disclosure of compliance reports, and a 30-day deadline for publishing federal reports. The bill became effective November 1, 2025.
